Zobrazeno 1 - 10
of 143
pro vyhledávání: '"K Tiev"'
Autor:
Laurent Arnaud, Emmanuelle Plaisier, Antoine Huart, Béatrice Mougenot, J.P. Rougier, K Tiev, Hélène François, A Kettaneh, Pierre Ronco
Publikováno v:
Clinical Nephrology. 68:165-170
The scleroderma renal crisis is characterized by acute onset of severe hypertension and by rapidly progressive hyperreninemic renal failure. There is, however, a very limited subset of patients with rapidly progressive renal failure who remain normot
Autor:
Dominique Farge, Zora Marjanovic, T. Papo, Olivier Meyer, D. Sereni, C. Tolédano, Olivier Chassany, K. Tiev, B. Crickx, Luc Mouthon, C. Heneggar, J. Cabane, C. Georges
Publikováno v:
Clinical Rheumatology. 24:3-10
The modified Scleroderma Health Assessment Questionnaire (SSc HAQ) is a functional score to assess systemic sclerosis (SSc) comprising the HAQ disease index (HAQ-DI) plus five specific visual analogue scales (VAS). Since it was validated in English-s
Publikováno v:
La Revue de medecine interne. 36(9)
Periungueal capillaroscopy is a simple and reliable non-invasive technique allowing evaluation of cutaneous microcirculation. It was promoted for decades in patients with Raynaud's phenomenon in order to differentiate between the benign primary Rayna
Autor:
M, Jammal, T, Deneuville, N, Mario, K, Tiev, C, Tolédano, L, Josselin-Mahr, D, Pateron, B, Guidet, A, Retbi, N, Taright, J, Cabane, A, Kettaneh
Publikováno v:
La Revue de medecine interne. 34(6)
To identify the diseases that are associated with a high plasma concentration of vitamin B12 and to measure the strength of this association.Retrospective study including all admissions between 1st May, 2005 and 30th April, 2008 in the UMAG pole depa
Autor:
M, Lam, M, Jammal, K, Tiev, C, Toledano, L, Fardet, S, Riviere, L, Josselin Mahr, J, Cabane, A, Kettaneh
Publikováno v:
La Revue de medecine interne. 33(8)
Pulmonary embolism is a frequent disorder with a diagnostic approach based on probability estimation. Nevertheless, in some cases, prognosis may be impaired by delayed diagnosis resulting from atypical presenting manifestations.We report a 37-year-ol
Autor:
Luc Mouthon, Philippe Ducrotté, Isabelle Marie, K. Tiev, Patrick Cherin, Pierre-Yves Hatron, Jean-François Ménard, Eric Hachulla
Publikováno v:
Arthritis careresearch. 62(12)
Objective To assess the long-term outcome of esophageal complications in the group of patients receiving intravenous immunoglobulins (IVIG) for the treatment of severe steroid-refractory esophageal involvement related to polymyositis/dermatomyositis
Autor:
L, Tselikas, E, Rodrigues, M, Jammal, K, Tiev, C, Chayet, L, Josselin-Mahr, M, Gain, C, Toledano, J, Cabane, A, Kettaneh
Publikováno v:
La Revue de medecine interne. 32(3)
The first manifestations of Becker's muscular dystrophy usually occur during childhood, as Duchenne's muscular dystrophy, a related disease. However, clinical presentation is usually more heterogeneous and less severe.We report a 54-year-old man who
Publikováno v:
La Revue de medecine interne. 31(8)
The objectives of this study were to evaluate: (1) the prevalence of anti-PM-Scl antibodies within the framework of antinuclear antibodies detection; and (2) the clinical features and outcome of patients with isolated polymyositis/dermatomyositis.Nin
Autor:
P, Dieudé, J, Wipff, M, Guedj, B, Ruiz, I, Melchers, E, Hachulla, G, Riemekasten, E, Diot, N, Hunzelmann, J, Sibilia, K, Tiev, L, Mouthon, J L, Cracowski, P H, Carpentier, J, Distler, Z, Amoura, I, Tarner, J, Avouac, O, Meyer, A, Kahan, C, Boileau, Y, Allanore
Publikováno v:
Arthritis and rheumatism. 60(11)
To determine whether the functional BANK1 variants rs3733197 and rs10516487 are associated with systemic sclerosis (SSc) in 2 European Caucasian populations and to investigate the putative gene-gene interactions between BANK1 and IRF5 as well as STAT
Autor:
I, Marie, L, Lahaxe, O, Benveniste, K, Delavigne, D, Adoue, L, Mouthon, E, Hachulla, J, Constans, K, Tiev, E, Diot, H, Levesque, O, Boyer, F, Jouen
Publikováno v:
The British journal of dermatology. 162(2)
To date, no series has analysed long-term outcome in patients with polymyositis/dermatomyositis (PM/DM) with anti-PM-Scl antibody.The aims of the present study were: (i) to assess clinical features and long-term outcome, including organ complications